Reuters Health Report

Click to View in Browser 05/22/2014 Brains of simple sea animals could help cure neural disorders ORLANDO Fla. (Reuters) - A Florida scientist studying simple sea animals called comb jellies has found the road map to a new form of brain development that could lead to treatments for Parkinson's, Alzheimer's and other neurodegenerative diseases. China anti-graft watchdog visits Roche amid pharma crackdown SHANGHAI/ZURICH (Reuters) - Swiss drugmaker Roche Holding AG ROG.VX said it had been visited by a unit of China's anti-trust regulator, apart of a widening crackdown on corruption and high prices in the country's pharmaceutical sector. Fake medicines worth $31 million seized in global crackdown LONDON (Reuters) - Law enforcement agents have arrested 237 people worldwide in a 10-day crackdown on fake drugs, resulting in the seizure of counterfeit and unlicensed medicines worth 18.6 million pounds ($31.4 million), Britain's healthcare watchdog said. Fear, MRIs tied to double mastectomy decision NEW YORK (Reuters Health) - Factors other than medical history and risk may influence women with cancer in one breast to have both breasts removed even if it doesn't improve their odds of survival, suggests a new study. E-cigarettes boost quitting success among smokers, study finds LONDON(Reuters) - Smokers trying to quit are 60 percent more likely to report success if they switch to e-cigarettes than if they use nicotine products like patches or gum, or just willpower, scientists said on Tuesday. Nevada to move online healthcare enrollment to federal site (Reuters) - Nevada's health insurance exchange board on Tuesday voted to transfer control over its online program from its vendor, Xerox, to the federal government's enrollment system. Isis Pharma's blood thinner succeeds in mid-stage trial (Reuters) - Isis Pharmaceuticals Inc said its experimental blood thinner was more effective than a commonly prescribed anticoagulant in patients undergoing total knee replacement surgery. J&J sees device growth through new products, emerging markets (Reuters) - Johnson & Johnson said on Thursday it planned to file for approvals of more than 30 major products by the end of 2016 as the diversified healthcare company looks to restore growth to a medical device and diagnostics division that has been overshadowed by its drugs business in recent years. Too little sleep can affect many aspects of young kids' health NEW YORK (Reuters Health) - In a new study, children who regularly got too little sleep had worse physical, emotional and social health than those who slept the average amount. Time may not reduce brain effects of solvent exposure NEW YORK (Reuters Health) - Workers exposed to solvents on the job may experience memory and thinking problems decades later, according to a new study. Related Video Reef fish lose brain power as oceans acidify Mystery fish stumps scientists The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend